Image via Wikipedia
Discovery sheds new light on the process of stem cell generation, and will help promote safer stem-cell based studies and future clinical trials.
Dr. Andras Nagy’s laboratory at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital and Dr. Timo Otonkoski’s laboratory at Biomedicum Stem Cell Center (University of Helsinki), as well as collaborators in Europe and Canada have identified genetic abnormalities associated with reprogramming adult cells to induced pluripotent stem (iPS) cells. The findings give researchers new insights into the reprogramming process, and will help make future applications of stem cell creation and subsequent use safer. The study was published online today in Nature.
The team showed that the reprogramming process for generating iPS cells (i.e., cells that can then be ‘coaxed’ to become a variety of cell types for use in regenerative medicine) is associated with inherent DNA damage. This damage is detected in the form of genetic rearrangements and ‘copy number variations,’ which are alterations of DNA in which a region of the genome is either deleted or amplified on certain chromosomes. The variability may either be inherited, or caused by de novo mutation.
“Our analysis shows that these genetic changes are a result of the reprogramming process itself, which raises the concern that the resultant cell lines are mutant or defective,” said Dr. Nagy, a Senior Investigator at the Lunenfeld. “These mutations could alter the properties of the stem cells, affecting their applications in studying degenerative conditions and screening for drugs to treat diseases. In the longer term, this discovery has important implications in the use of these cells for replacement therapies in regenerative medicine.”
“Our study also highlights the need for rigorous characterization of generated iPS lines, especially since several groups are currently trying to enhance reprogramming efficiency,” said Dr. Samer Hussein, a McEwen post-doctoral scientist who initiated these studies with Dr. Otonkoski, before completing them with Dr. Nagy. “For example, increasing the efficiency of reprogramming may actually reduce the quality of the cells in the long run, if genomic integrity is not accurately assessed.”
Continue reading ‘Genetic abnormalities associated with the creation of stem cells’
Incoming search terms:
kinds of abnormalities, latest abnormalities, what kind of abnormality are associated with stem cell, cellular reprogramming snp, abnormalities induced pluripotency, SNP in hematopoietic stem cell line, stem cell research abnormalities, stem cells abnormalities, study of cell abnormalities, study of cell abnormalities?, STUDY OF STEM CELL ABnormality, Vit C Estool, what is the latest abnormalities, what kind of babnormalities associated with stem cell, Our analysis shows that these genetic changes are a result of the reprogramming process itself which raises the concern that the resultant cell lines are mutant or defective, otonkoski stem cells, ontario ministry research innovation paralysis stem cell, andras nagy estools, creations lab stem cell, dr nagy chromosome ips cel, finding snp in patients stem cell, genetic rearrangements in progenetor cells-cancer, genetic rearrangements in progenitor cells learn through animation, how does cellular reprogramming cure chromosomal abnormalities, IPS Stem Cells: New Ethical Quandaries, kind of abnormalities, Nagy and stem cells, what kinds of abnormalities are associated with stem cells.
